Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

EPHA2 (EPH receptor A2)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

‹

TheraPrint® test

TheraPrint® test

›

EPHA2 overexpression + EGFR overexpression	Colorectal Cancer	EPHA2 overexpression + EGFR overexpression	Colorectal Cancer	cetuximab Resistant: C3 – Early Trials cetuximab Resistant : C3	cetuximab Resistant: C3 – Early Trials cetuximab Resistant : C3
EPHA2 underexpression	Colorectal Cancer	EPHA2 underexpression	Colorectal Cancer	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3	cetuximab Sensitive: C3 – Early Trials cetuximab Sensitive : C3
EPHA2 G391R	Non Small Cell Lung Cancer	EPHA2 G391R	Non Small Cell Lung Cancer	sirolimus Sensitive: D – Preclinical sirolimus Sensitive : D	sirolimus Sensitive: D – Preclinical sirolimus Sensitive : D
EPHA2 expression + EGFR mutation	Non Small Cell Lung Cancer	EPHA2 expression + EGFR mutation	Non Small Cell Lung Cancer	BCY6033 Sensitive: D – Preclinical BCY6033 Sensitive : D	BCY6033 Sensitive: D – Preclinical BCY6033 Sensitive : D